New products are live, and we’ve lowered prices across the catalog. Free overnight shipping on orders over $200.

Metabolic Pens

Semaglutide 1.5mg Pen

$60.00

Semaglutide 0.6 mL Pen

The Science, Simplified: Semaglutide is a synthetic peptide studied as a GLP-1 receptor agonist research compound.

Product Specifications – Semaglutide 1.5 mg 0.6 mL Pen

  • Total Semaglutide: 1.5 mg
  • Volume: 0.6 mL pre-filled pen
  • Clicks in the pen: 60
  • Volume per click: 0.01 mL
  • Dial range: 1–60 clicks per dispensing (0.01–0.60 mL)
  • Peptide per click: 25 mcg Semaglutide
  • Concentration: 2.5 mg/mL
  • Purity: ≥99%, third-party tested (COA available)
  • Format: Ready-to-use multi-use pre-filled pen
  • Also available research strengths: 3.5 mg, 5.5 mg, 7.5 mg, 10 mg, 15 mg pens

Key Research Focus: GLP-1 receptor and incretin-pathway research.

Physical Form & Solubility:

  • Appearance: Clear to slightly opalescent liquid
  • Solubility: Already in aqueous solution. Highly soluble; no reconstitution required.

Pen Format Details: The 0.6 mL pre-filled pen is a multi-use system designed for precise, consistent dispensing of the research compound. It features a sealed cartridge and dial mechanism for accurate volume control. The pen is ready for immediate laboratory use with no mixing or transfer steps required. Each pen is labeled with total peptide content and lot-specific COA reference.

Stability & Handling Notes:

  • Refrigerated at 2–8°C (36–46°F). Practical shelf life is 12–16 weeks when protected from light and handled with clean laboratory technique.
  • Do not freeze. Avoid prolonged room-temperature exposure.
  • Store upright in the original packaging with the cap on, and avoid temperature swings. Discard if the solution becomes cloudy, discolored, or shows particles.
  • Protect from light and moisture at all times.

Semaglutide Research Studies

Selected English-language peer-reviewed references for laboratory research context. Links open publisher or PubMed/PMC records.

Read the Semaglutide research overview

  1. Once-Weekly Semaglutide in Adults with Overweight or ObesityPubMed 33567185
  2. Effect of Continued Weekly Subcutaneous Semaglutide vs Placebo on Weight Loss MaintenancePubMed 33755728
  3. Two-year effects of semaglutide in adults with overweight or obesity: the STEP 5 trialPubMed 36216945
  4. Semaglutide and Cardiovascular Outcomes in Patients with Type 2 DiabetesPubMed 27633186
  5. Semaglutide and Cardiovascular Outcomes in Obesity without DiabetesPubMed 37952131
Semaglutide amino acid chain
Semaglutide — amino acid chain (N→C)